(A) Schematic for establishing endometrial assembloids. (B) Structural appearance of hematoxylin and eosin stained secretory endometrium, E-cadherin labelled gland-like organoids, and E-cadherin and …
Secretion of PRL and CXCL14 by endometrial assembloids.
Secretion of PRL and CXCL 14 (pg/ml) was measured by ELISA in spent medium from assembloids. Supports Figure 1D.
Parallel gland-like organoids (red) and assembloids (blue) were established from three endometrial biopsies and decidualized with 8-bromo-cAMP and MPA for 4 days in either expansion medium (ExM), …
RTqPCR data associated with the minimal differentiation medium (MDM) experiments.
Parallel epithelial gland organoids and assembloids were established from endometrial biopsies and decidualized with 8-bromo-cAMP and MPA for 4 days in either expansion medium (ExM), base medium (BM), or BM with each exogeneous factor added back individually (red).
(A) Schematic overview of experimental design. ExM: expansion medium; MDM: minimal differentiation medium. (B) Uniform Manifold Approximation and Projection (UMAP) visualizing epithelial and stromal …
Epithelial subpopulation markers.
Population markers were generated in Seurat v3 using FindMarkers on specified comparisons. Supports Figure 3C.
GO analysis of differentiated subpopulations.
Stromal sub-population markers.
Population markers were generated in Seurat v3 using FindMarkers on specified comparisons. Supports Figure 3E.
Supports Figure 3C.
Supports Figure 3C.
Supports Figure 3D.
(A) Heatmap showing the total number of cell-cell interactions predicted by CellPhoneDB between different subpopulations in decidualizing assembloids. (B) Dot plots of representative ligand-receptor …
CellPhoneDB prediction of cell-cell interactions.
Ligand-receptor interactions were predicted using CellPhoneDB on counts data from Seurat v3.
(A) Schematic overview of experimental design. ExM: expansion medium; MDM: minimal differentiation medium. (B) Uniform Manifold Approximation and Projection (UMAP) visualization (left panel) and …
Differentially expressed genes for day 4 populations treated with and without dasatinib.
Specified pairwise comparisons were generated in Seurat v3 using FindMarkers. Supports Figure 5C.
GO analysis for day 4 populations treated with and without dasatinib.
ELISA data.
Secreted levels of key senescent (CXCL8) and decidual stromal cell markers (CXCL14, IL-15, TIMP3) (pg/ml) were examined by ELISA in spent medium from assembloids treated with or without dasatinib. Supports Figure 5D.
(A) Diagram showing experimental design. ExM: expansion medium; MDM: minimal differentiation medium; EM: embryo medium. (B) Schematic drawing of co-culture method. (C) Representative time-lapse …
Embryo expansion measurement.
Embryo diameters were measured over 72 hr co-culture with assembloids previously differentiated with or without dasatinib. Images were captured using time-lapse imaging. Supports Figure 6D.
Embryo human chorionic gonadotropin (hCG) secretion.
Secreted levels of hCG (pg/ml) by embryos in co-culture with assembloids previously differentiated with or without dasatinib were examined by ELISA in spent medium. Supports Figure 6F.
Images were captured by time-lapse microscopy and annotated to indicate the frontier of the stromal egress (white dotted line).
Time-course images of endometrial assembloids in minimal differentiation medium (MDM) supplemented or not with dasatinib. Scale bar = 50 µm. Supports Figure 6C.
Dot size indicates the proportion of cells expressing the marker, while colour indicates the level of expression. Note that none of the cell populations express a compelling luminal epithelial …
Representative video of a human blastocyst embedded in an assembloid, as imaged by time-lapse microscopy over 72 hr with images captured every 60 min.
Representative video of a human blastocyst embedded in an assembloid which had been pre-treated with dasatinib, as imaged by time-lapse microscopy over 72 hr with images captured every 60 min.
Supplementary tables 1-3.
Table 1. Culture media composition. Table 2. Patient demographics for endometrial samples. Table 3. Antibody details for immunofluorescence labelling.